Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2014, Article ID 348189, 9 pages
http://dx.doi.org/10.1155/2014/348189
Research Article

Methanol Extract of Euchelus asper Prevents Bone Resorption in Ovariectomised Mice Model

1The Department of Zoology, The D.G. Ruparel College, Senapati Bapat Marg, Mahim, Mumbai 400016, India
2Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, India

Received 10 January 2014; Revised 10 May 2014; Accepted 19 May 2014; Published 5 June 2014

Academic Editor: Klaus Engelke

Copyright © 2014 Babita Balakrishnan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Davey, “Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons,” The South African Medical Journal, vol. 102, no. 5, pp. 285–288, 2012. View at Google Scholar · View at Scopus
  2. D. K. Dhanwal, E. M. Dennison, N. C. Harvey, and C. Cooper, “Epidemiology of hip fracture: worldwide geographic variation,” Indian Journal of Orthopaedics, vol. 45, no. 1, pp. 15–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Gao, R. Tiwari-Pandey, R. Samadfam et al., “Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone,” Endocrinology, vol. 148, no. 6, pp. 2613–2621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Pacifici, “The immune system and bone,” Archives of Biochemistry and Biophysics, vol. 503, no. 1, pp. 41–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Canderelli, L. A. Leccesse, and N. L. Miller, “Benefits of hormone replacement therapy in postmenopausal women,” Journal of the American Academy of Nurse Practitioners, vol. 19, no. 12, pp. 635–641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Cauley, J. Robbins, Z. Chen et al., “Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women's health initiative randomized trial,” The Journal of the American Medical Association, vol. 290, no. 13, pp. 1729–1738, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Apte, Field Guide to the Marine Life of India, Stusa Mudra Private Limited, Mumbai, India, 2012.
  8. W. E. G. Müller, X. Wang, K. P. Jochum, and H. C. Schröder, “Self healing, an intrinsic property of biomineralisation processes,” International Union of Biochemistry and Molecular Biology Life, vol. 65, no. 5, pp. 382–396, 2013. View at Publisher · View at Google Scholar
  9. F. Marin and G. Luquet, “Molluscan shell proteins,” Comptes Rendus—Palevol, vol. 3, no. 6-7, pp. 469–492, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Akerkar, C. A. Ponkshe, and M. M. Indap, “Evaluation of immunomodulatory activity of extracts from marine animals,” Indian Journal of Marine Sciences, vol. 38, no. 1, pp. 22–27, 2009. View at Google Scholar · View at Scopus
  11. S.-S. Gu, Y. Zhang, X.-L. Li et al., “Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice,” Bioscience, Biotechnology and Biochemistry, vol. 76, no. 7, pp. 1367–1371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Yamaguchi, R. Hamamoto, S. Uchiyama, K. Ishiyama, and K. Hashimoto, “Anabolic effects of bee pollen Cistus ladaniferus extract on bone components in the femoral-diaphyseal and -metaphyseal tissues of rats in vitro and in vivo,” Journal of Health Science, vol. 52, no. 1, pp. 43–49, 2006. View at Google Scholar · View at Scopus
  13. S. Uchiyama, K. Ishiyama, K. Hashimoto, and M. Yamaguchi, “Synergistic effect of β-cryptoxanthin and zinc sulfate on the bone component in rat femoral tissues in Vitro: the unique anabolic effect with zinc,” Biological and Pharmaceutical Bulletin, vol. 28, no. 11, pp. 2142–2145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Google Scholar · View at Scopus
  15. H. B. Kwak, B. K. Lee, J. Oh et al., “Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression,” Bone, vol. 46, no. 3, pp. 724–731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Swarnkar, K. Sharan, J. A. Siddiqui et al., “A novel flavonoid isolated from the steam-bark of Ulmus Wallichiana Planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation,” European Journal of Pharmacology, vol. 658, no. 2-3, pp. 65–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-H. Lim, T.-Y. Ha, S.-R. Kim, J. Ahn, H. J. Park, and S. Kim, “Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats,” British Journal of Nutrition, vol. 101, no. 7, pp. 1031–1039, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Li, L.-P. Qin, T. Han, Y.-B. Wu, Q.-Y. Zhang, and H. Zhang, “Inhibitory effects of morinda officinalis extract on bone loss in ovariectomized rats,” Molecules, vol. 14, no. 6, pp. 2049–2061, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Matsui and M. Yamaguchi, “Zinc modulation of insulin-like growth factor's effect in osteoblastic MC3T3-E1 cells,” Peptides, vol. 16, no. 6, pp. 1063–1068, 1995. View at Google Scholar · View at Scopus
  20. T. Hertrampf, B. Schleipen, M. Velders, U. Laudenbach, K. H. Fritzemeier, and P. Diel, “Estrogen receptor subtype-specific effects on markers of bone homeostasis,” Molecular and Cellular Endocrinology, vol. 291, no. 1-2, pp. 104–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Jackson, U. T. Iwaniec, R. T. Turner, T. J. Wronski, and S. P. Kalra, “Effects of increased hypothalamic leptin gene expression on ovariectomy-induced bone loss in rats,” Peptides, vol. 32, no. 8, pp. 1575–1580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Zhang, W.-P. Lai, P.-C. Leung, C.-F. Wu, and M.-S. Wong, “Short- to mid-term effects of ovariectomy on bone turnover, bone mass and bone strength in rats,” Biological and Pharmaceutical Bulletin, vol. 30, no. 5, pp. 898–903, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Yamaguchi and M. N. Weitzmann, “The estrogen 17β-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-κB activity,” International Journal of Molecular Medicine, vol. 23, no. 2, pp. 297–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. D. Papaconstantinou, T. H. Umbreit, B. R. Fisher, P. L. Goering, N. T. Lappas, and K. M. Brown, “Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: role of the estrogen receptor,” Toxicological Sciences, vol. 56, no. 2, pp. 332–339, 2000. View at Google Scholar · View at Scopus
  25. S. Hidaka, Y. Okamoto, S. Uchiyama et al., “Royal jelly prevents osteoporosis in rats: beneficial effects in ovariectomy model and in bone tissue culture model,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 339–348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-J. Body, P. Bergmann, S. Boonen et al., “Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications,” Osteoporosis International, vol. 23, no. 1, pp. S1–S23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Lombardi, P. Lanteri, A. Colombini, and G. Banfi, “Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 5, pp. 771–789, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Demontiero, C. Vidal, and G. Duque, “Aging and bone loss: new insights for the clinician,” Therapeutic Advances in Musculoskeletal Disease, vol. 4, no. 2, pp. 61–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. D. B. Burr and M. A. Gallant, “Bone remodelling in osteoarthritis,” Nature Reviews Rheumatology, vol. 8, no. 11, pp. 665–672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kinugawa, S. Fukuzawa, and K. Tachibana, “Skeletal protein protection: the mode of action of an anti-osteoporotic marine alkaloid, norzoanthamine,” Journal of Bone and Mineral Metabolism, vol. 27, no. 3, pp. 303–314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Z. Ke, H. K. Chen, H. A. Simmons et al., “Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model,” Bone, vol. 20, no. 1, pp. 31–39, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Xie, C.-F. Wu, W.-P. Lai et al., “The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 353–361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Yamaguchi, “Role of carotenoid β-cryptoxanthin in bone homeostasis,” Journal of Biomedical Science, vol. 19, no. 1, article no. 36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Yamaguchi, S. Uchiyama, K. Ishiyama, and K. Hashimoto, “Oral administration in combination with zinc enhances β-cryptoxanthin- induced anabolic effects on bone components in the femoral tissues of rats in vivo,” Biological and Pharmaceutical Bulletin, vol. 29, no. 2, pp. 371–374, 2006. View at Google Scholar · View at Scopus
  35. N. L. Fazzalari, “Bone remodeling: a review of the bone microenvironment perspective for fragility fracture (osteoporosis) of the hip,” Seminars in Cell and Developmental Biology, vol. 19, no. 5, pp. 467–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Hayman, “Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy,” Autoimmunity, vol. 41, no. 3, pp. 218–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Kazami, M. Muroi, M. Kawatani et al., “Iejimalides show anti-osteoclast activity via V-ATPase inhibition,” Bioscience, Biotechnology and Biochemistry, vol. 70, no. 6, pp. 1364–1370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Balakrishnan, M. Indap, S. P. Singh, C. M. Krishna, and S. V. Chiplunkar, “Turbo methanol extract inhibits bone resorption through regulation of T cell function,” Bone, vol. 58, pp. 114–125, 2014. View at Google Scholar